Genmab — Januar 2017
-
Så er Roche's anti cd20 ved at nå målet i MS http://www.fiercepharma.com/special-report/1-ocrevus
-
Defensiv fordi den ikke er cyklist = konjukturafhængig.. :)... Solgt ud af alle aktier idag - tror Trump får skabt meget nervøsitet i kommende tid.. og ingen ved, hvad han finder på, når pharma lander på hans agenda... går sikkert fri at det opløb der teknisk set står her efter 1300 ... men synes der er stor risiko i øjelblikket...
-
M.D.Anderson:Neoadjuvant Listeria or Daratumumab in Prostate Cancer.https://clinicaltrials.gov/ct2/show/NCT03035357?term=daratumumab&rank=1
-
nivolumab in combination with ipilimumab, BMS-986016 or daratumumab in human subjects who have the following types of tumors: Epstein Barr Virus (EBV) positive gastric cancer; EBV positive nasopharyngeal cancer (NPC); Human Papilloma Virus (HPV) positive cervical, vaginal, vulvar cancer; Other HPV-associated tumors (anal canal, penile), HPV positive squamous cell cancer of the head and neck (SCCHN); and Polyomavirus positive merkel cell cancer
-
BMS; A Study to Investigate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab Combination Therapy in Virus-associated Tumors (CheckMate358) https://clinicaltrials.gov/ct2/show/NCT02488759?term=daratumumab&rank=37
-
Interessant - https://twitter.com/clahjoh/status/825485297261694976
-
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind